EuroEyes Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend

Bulletin Express
Aug 14

EuroEyes International Eye Clinic Limited has scheduled a board meeting for 31 August 2026. Directors will review and approve the consolidated interim results for the six months ended 30 June 2026 and determine whether to recommend an interim dividend. Additional routine business matters may also be transacted during the session.

The Board currently consists of five executive directors—Dr. Jørn Slot Jørgensen, Mr. Jannik Jonas Slot Jørgensen, Professor Dan Zoltan Reinstein, Mr. Marcus Huascar Bracklo and Mr. Rens Laurentius Michaël Schoenmakers—along with three independent non-executive directors: Mr. Hans Helmuth Hennig, Ms. Katherine Rong Xin and Mr. Philip Duncan Wright. Rosenna Ho serves as company secretary.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10